Conference Coverage

This channel highlights DAIC's coverage of numerous key cardiology and medical imaging conferences each year. These include ACC, AHA, ASE, ASNC, EuroPCR, ECR, HIMSS, HRS, RSNA, SCAI, SCCT, TCT, and VIVA.

Videos | Structural Heart

VIDEO: Interventional Structural Heart Advances Are Rapidly Expanding

Juan F. Granada, M.D., CEO of the Cardiovascular Research Foundation (CRF) explains structural heart innovations and new ...

September 16, 2020

The Epiq CVxi being used for TEE imaging in the cath lab. The system brings together advanced image quality, quantification and intelligence specifically for the cardiologist.

News | Cardiovascular Ultrasound

Philips Expands Cardiovascular Ultrasound With Affiniti CVx to Increase Productivity

September 15, 2020 — Philips Healthcare recently introduced the latest addition to its portfolio of dedicated cardiovasc ...

September 15, 2020

Videos | Pharmaceuticals

VIDEO: Icosapent Ethyl Significantly Reduces Coronary Plaque in EVAPORATE Study

Matthew Budoff, M.D., director of cardiovascular CT at The Lundquist Institute, and professor of medicine at the David ...

September 10, 2020

Icosapent ethyl (Vascepa) demonstrated significant, 17 percent regression of low attenuation plaque (LAP) volume on multidetector computed tomography (MDCT) compared with placebo over 18 months in the EVAPORATE Trial

News | Pharmaceuticals

Icosapent Ethyl Significantly Reduces Coronary Plaque in EVAPORATE Study

September 10, 2020 - Icosapent ethyl (Vascepa) demonstrated significant, 17 percent regression of low attenuation plaque ...

September 10, 2020

Videos | Drug-Eluting Balloons

VIDEO: Overview of Drug-coated Balloons

Juan F. Granada, M.D., CEO of the Cardiovascular Research Foundation (CRF) worked on preclinical development work for a ...

September 09, 2020

Biotronik's closed loop stimulation (CLS) technology helps reduce unexplained fainting in patients with recurrent episodes due to skipped heartbeats. #ESC2020

News | EP Lab

Study Shows Severe Fainting Can Be Treated with Cardiac Pacing Supported by Closed Loop Stimulation

September 8, 2020 - A new study presented at the 2020 European Society of Cardiology (ESC) Congress shows that Biotronik ...

September 08, 2020

News | Coronavirus (COVID-19)

First Randomized Trial Backs Safety of ACE and ARB Heart Drugs in COVID-19 Patients

September 8, 2020 - Heart patients hospitalized with COVID-19 (SARS-CoV-2) can safely continue taking angiotensin ...

September 08, 2020

Videos | TCT

VIDEO: What to Expect at the Virtual TCT 2020 Meeting

With COVID-19 forcing all medical conferences to go virtual in 2020, Juan F. Granada, M.D., CEO of the Cardiovascular ...

August 01, 2020

Echocardiography strain imaging at ASE. #ASE2020

News | ASE

ASE Features Top 20 Echocardiography Research Abstract Presentations

August 20, 2020 – More than 350 posters featuring cutting edge research on the advances in cardiovascular ultrasound ...

August 20, 2020

The World Alliance of Societies of Echocardiography (WASE) Normal Values Study is a cross-sectional study designed to obtain universal global reference ranges for both 2-D and 3-D echocardiographic (2DE, 3DE) data to identify geographical differences in echocardiographic measurements. Launched in 2016, the WASE study prospectively enrolled healthy individuals free from cardiac, lung, and kidney disease from 19 centers in 15 countries. #ASE #ASE2020

News | Cardiovascular Ultrasound

WASE Study Finds Differences in How Right Atrial Size is Reported in Non-Asian and Asian Patients

August 20, 2020 – The World Alliance of Societies of Echocardiography (WASE) Normal Values Study is a cross-sectional ...

August 20, 2020

In the era of COVID-19, remote technical assistance has become big deal. GE Healthcare showed its Digital Expert technology at the ASE 2020 virtual meeting, which allows remote one-on-one echo training or ultrasound machine technical assistance. It became an important service for GE since the start of the pandemic.

Feature | ASE

Innovative Cardiovascular Ultrasound Solutions Showcased at ASE 2020 Virtual Meeting

August 19, 2020 — From point-of-care ultrasound (POCUS) that has been a key technology during the COVID-19 pandemic, to ...

August 19, 2020

$aption Health a leader in medical AI technology, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an updated version of Caption Interpretation, which uses artificial intelligence (AI) to enable clinicians to obtain quick, easy and accurate measurements of cardiac ejection fraction (EF) at the point of care.$

News | Artificial Intelligence

FDA Clears Caption Health AI-assisted Point-of-care Ejection Fraction Evaluation

August 19, 2020 — Caption Health a leader in medical AI technology, has received U.S. Food and Drug Administration (FDA) ...

August 19, 2020

In February 2020, the U.S. Food and Drug Administration (FDA) cleared artificial intelligence software to assist in the acquisition of cardiac ultrasound images. The Caption Guidance software from Caption Health is an accessory to compatible diagnostic ultrasound systems and uses artificial intelligence to help the user capture images of a patient’s heart that are of acceptable diagnostic quality. It is aimed at point of care ultrasound (POCUS) exams, where users may not be regular sonographers.

Feature | Artificial Intelligence | Dave Fornell, Editor

Artificial Intelligence Applications in Cardiology

The No. 1 overarching hot topic at all the medical conferences over the past couple years has been artificial ...

August 18, 2020

COVID-19 has a big impact on the heart, and patients with pre-existing cardiovascular disease have at least a 10 percent higher risk of death and severe complications due to the virus. The virus also can cause myocarditis, blood clotting, and impact the cardiovascular system due to severe, hyperactive inflammatory responses. Left, a cardiac CT scan 3-D rendering. right, the COVID-19 virus from a National Institutes of Health (NIH) photo.

Feature | Coronavirus (COVID-19)

AHA Explains Severe COVID-19 is Closely Associated With Heart Issues

August 17, 2020 - The number of people coronavirus disease 2019 (COVID-19) is rising with more cases in the U.S. There ...

August 17, 2020

Sheer stresses on the walls of arteries are believed to cause the formation atherosclerotic plaques. This is an area of research that is expected to see increased use in the next few years. This study was presented at SCCT 2020 as an example of how sheer stresses can help evaluate and predict the patency of coronary artery bypass grafts (CABG). #SCCT2020 #yesCCT

Feature | CT Angiography (CTA) | Dave Fornell, Editor

Key Trends in Cardiac CT at SCCT 2020

The latest technical advances and trends in computed tomography (CT) and the latest clinical study data were discussed ...

August 14, 2020